West Pharmaceutical Services/$WST
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About West Pharmaceutical Services
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Ticker
$WST
Sector
Primary listing
NYSE
Employees
10,600
Headquarters
Website
WST Metrics
BasicAdvanced
$19B
40.15
$6.75
1.07
$0.84
0.31%
Price and volume
Market cap
$19B
Beta
1.07
52-week high
$348.90
52-week low
$187.43
Average daily volume
721K
Dividend rate
$0.84
Financial strength
Current ratio
2.87
Quick ratio
2.016
Long term debt to equity
9.179
Total debt to equity
9.93
Dividend payout ratio (TTM)
12.34%
Profitability
EBITDA (TTM)
801.4
Gross margin (TTM)
35.58%
Net profit margin (TTM)
16.29%
Operating margin (TTM)
21.08%
Effective tax rate (TTM)
20.28%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
10.22%
Return on equity (TTM)
16.94%
Valuation
Price to earnings (TTM)
40.145
Price to revenue (TTM)
6.502
Price to book
6.39
Price to tangible book (TTM)
6.65
Price to free cash flow (TTM)
51.763
Free cash flow yield (TTM)
1.93%
Free cash flow per share (TTM)
5.236
Dividend yield (TTM)
0.31%
Forward dividend yield
0.31%
Growth
Revenue change (TTM)
4.92%
Earnings per share change (TTM)
0.17%
3-year revenue growth (CAGR)
1.23%
10-year revenue growth (CAGR)
8.06%
3-year earnings per share growth (CAGR)
-6.47%
10-year earnings per share growth (CAGR)
18.09%
3-year dividend per share growth (CAGR)
5.27%
10-year dividend per share growth (CAGR)
6.68%
What the Analysts think about WST
Analyst ratings (Buy, Hold, Sell) for West Pharmaceutical Services stock.
Bulls say / Bears say
West reported Q2 2025 net sales of $766.5 million, up 9.2% year over year (6.8% organic growth), driven by strength in high-value product components and demand for GLP-1 elastomers, exceeding Wall Street estimates (PRNewswire)
The company’s gross profit margin increased to 35.7% in Q2, compared to 32.8% last year, and operating profit margin rose to 20.1% from 18.0% in Q2 2024, reflecting strong pricing power and a shift toward higher-margin products (Investing.com)
West raised its full-year 2025 net sales guidance to $3.04–$3.06 billion (from $2.945–$2.975 billion) and increased adjusted-diluted EPS guidance to $6.65–$6.85 (from $6.15–$6.35), citing strong GLP-1 demand and favorable foreign exchange effects (PRNewswire)
Data summarised monthly by Lightyear AI. Last updated on 7 Nov 2025.
WST Financial Performance
Revenues and expenses
WST Earnings Performance
Company profitability
WST News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for West Pharmaceutical Services stock?
West Pharmaceutical Services (WST) has a market cap of $19B as of November 08, 2025.
What is the P/E ratio for West Pharmaceutical Services stock?
The price to earnings (P/E) ratio for West Pharmaceutical Services (WST) stock is 40.15 as of November 08, 2025.
Does West Pharmaceutical Services stock pay dividends?
Yes, the West Pharmaceutical Services (WST) stock pays dividends to shareholders. As of November 08, 2025, the dividend rate is $0.84 and the yield is 0.31%. West Pharmaceutical Services has a payout ratio of 12.34% on a trailing twelve-month basis.
When is the next West Pharmaceutical Services dividend payment date?
The next West Pharmaceutical Services (WST) dividend payment is scheduled for November 19, 2025.
What is the beta indicator for West Pharmaceutical Services?
West Pharmaceutical Services (WST) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.